Regorafenib (off Label)
Regorafenib in ACC
Memorial Sloan Kettering (investigator) · Phase 2 · Completed · Enrollment 38
| Arm | Population | Dose | Estimand | Comparator | Efficacy |
|---|---|---|---|---|---|
| Regorafenib | progressive R/M ACC (n = 38) | not stated in source | Single arm | n/r | responders (CR or PR): 1 patients (of 38), results posted 09.10.2025 |